MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based […]
ZYNLONTA® (loncastuximab tesirine-lpyl) net sales of $17.8 million in 1Q 2024; total operating expenses decreased 25% (adjusted total operating expenses […]
PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, […]
1000 Kazakh and international delegates participate in the annual conference, discussing artificial intelligence, big data analytics and app development in […]